Birchview Capital’s Cullinan Oncology CGEM Stock Holding History

Birchview Capital’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$284K	Hold	20,000	–	–	0.16%	64
2025 Q4	$207K	Hold	20,000	–	–	0.12%	64
2025 Q3	$119K	Hold	20,000	–	–	0.09%	66
2025 Q2	$151K	Hold	20,000	–	–	0.15%	63
2025 Q1	$151K	Hold	20,000	–	–	0.13%	57
2024 Q4	$244K	Hold	20,000	–	–	0.2%	53
2024 Q3	$335K	Hold	20,000	–	–	0.29%	41
2024 Q2	$349K	Sell	20,000 -5,114	-20%	-$109K	0.32%	40
2024 Q1	$428K	Hold	25,114	–	–	0.35%	38
2023 Q4	$256K	Hold	25,114	–	–	0.2%	45
2023 Q3	$227K	Hold	25,114	–	–	0.19%	44
2023 Q2	$270K	Hold	25,114	–	–	0.2%	48
2023 Q1	$257K	Hold	25,114	–	–	0.2%	46
2022 Q4	$265K	Hold	25,114	–	–	0.19%	46
2022 Q3	$322K	Sell	25,114 -20,000	-44%	-$269K	0.23%	46
2022 Q2	$578K	Hold	45,114	–	–	0.42%	35
2022 Q1	$472K	Hold	45,114	–	–	0.34%	42
2021 Q4	$696K	Hold	45,114	–	–	0.45%	36
2021 Q3	$1.02M	Hold	45,114	–	–	0.69%	28
2021 Q2	$1.16M	Sell	45,114 -15,000	-25%	-$461K	0.7%	25
2021 Q1	$2.5M	Buy	+60,114	New	+$2.44M	1.49%	12

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return